Rebecca Lever

1.6k total citations
18 papers, 1.2k citations indexed

About

Rebecca Lever is a scholar working on Molecular Biology, Behavioral Neuroscience and Hematology. According to data from OpenAlex, Rebecca Lever has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Behavioral Neuroscience and 5 papers in Hematology. Recurrent topics in Rebecca Lever's work include Stress Responses and Cortisol (5 papers), Glycosylation and Glycoproteins Research (3 papers) and Platelet Disorders and Treatments (3 papers). Rebecca Lever is often cited by papers focused on Stress Responses and Cortisol (5 papers), Glycosylation and Glycoproteins Research (3 papers) and Platelet Disorders and Treatments (3 papers). Rebecca Lever collaborates with scholars based in United Kingdom, Italy and United States. Rebecca Lever's co-authors include Clive Page, Peter S. Whitton, Amjad Abuirmeileh, Alexander Harkavyi, John Hogwood, Elaine Gray, Barbara Mulloy, Ann E. Kingsbury, Christopher S. Biggs and Steve Brocchini and has published in prestigious journals such as The Journal of Immunology, The FASEB Journal and Pharmacological Reviews.

In The Last Decade

Rebecca Lever

18 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rebecca Lever United Kingdom	15	330	190	184	181	175	18	1.2k
Peter Schmid Germany	20	864 2.6×	228 1.2×	99 0.5×	122 0.7×	131 0.7×	41	1.6k
Mónika Göőz United States	24	754 2.3×	282 1.5×	105 0.6×	317 1.8×	93 0.5×	60	1.8k
Yutaka Imamura Japan	32	1.1k 3.4×	125 0.7×	111 0.6×	98 0.5×	232 1.3×	118	4.8k
Keisuke Okabe Japan	19	618 1.9×	302 1.6×	121 0.7×	212 1.2×	56 0.3×	73	1.7k
Julia Winkler United States	22	619 1.9×	188 1.0×	56 0.3×	133 0.7×	64 0.4×	74	1.6k
Heming Wu China	27	1.1k 3.5×	455 2.4×	167 0.9×	189 1.0×	153 0.9×	133	2.4k
Kamlesh Asotra United States	20	845 2.6×	280 1.5×	99 0.5×	188 1.0×	37 0.2×	46	2.0k
R.A.D. Bunning United Kingdom	28	567 1.7×	360 1.9×	135 0.7×	218 1.2×	31 0.2×	59	2.0k

Countries citing papers authored by Rebecca Lever

Since Specialization

Citations

This map shows the geographic impact of Rebecca Lever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Lever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Lever more than expected).

Fields of papers citing papers by Rebecca Lever

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca Lever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Lever. The network helps show where Rebecca Lever may publish in the future.

Co-authorship network of co-authors of Rebecca Lever

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca Lever. A scholar is included among the top collaborators of Rebecca Lever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca Lever. Rebecca Lever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Hossain, Amjad, et al.. (2019). Preparation, Characterisation, and Topical Delivery of Terbinafine. Pharmaceutics. 11(10). 548–548. 22 indexed citations

Mulloy, Barbara, John Hogwood, Elaine Gray, Rebecca Lever, & Clive Page. (2015). Pharmacology of Heparin and Related Drugs. Pharmacological Reviews. 68(1). 76–141. 243 indexed citations

Khalili, Hanieh, et al.. (2014). Pegylation and Its Impact on the Design of New Protein-Based Medicines. Future Medicinal Chemistry. 6(16). 1829–1846. 74 indexed citations

Lever, Rebecca, Mark J. Rose, Edward A. McKenzie, & Clive Page. (2014). Heparanase induces inflammatory cell recruitment in vivo by promoting adhesion to vascular endothelium. American Journal of Physiology-Cell Physiology. 306(12). C1184–C1190. 42 indexed citations

Khalili, Hanieh, Antony Godwin, Ji-Won Choi, et al.. (2013). Fab-PEG-Fab as a Potential Antibody Mimetic. Bioconjugate Chemistry. 24(11). 1870–1882. 39 indexed citations

Khalili, Hanieh, Antony Godwin, Ji-Won Choi, Rebecca Lever, & Steve Brocchini. (2012). Comparative Binding of Disulfide-Bridged PEG-Fabs. Bioconjugate Chemistry. 23(11). 2262–2277. 53 indexed citations

Abuirmeileh, Amjad, Alexander Harkavyi, Rebecca Lever, et al.. (2012). Exendin-4 treatment enhances L-DOPA evoked release of striatal dopamine and decreases dyskinetic movements in the 6-hydoxydopamine lesioned rat. Journal of Pharmacy and Pharmacology. 64(5). 637–643. 25 indexed citations

Abuirmeileh, Amjad, Alexander Harkavyi, Ann E. Kingsbury, Rebecca Lever, & Peter S. Whitton. (2008). The CRF-like peptide urocortin produces a long-lasting recovery in rats made hemiparkinsonian by 6-hydroxydopamine or lipopolysaccharide. Journal of the Neurological Sciences. 271(1-2). 131–136. 10 indexed citations

Abuirmeileh, Amjad, Alexander Harkavyi, Ann E. Kingsbury, Rebecca Lever, & Peter S. Whitton. (2008). The CRF-like peptide urocortin greatly attenuates loss of extracellular striatal dopamine in rat models of Parkinson's disease by activating CRF1 receptors. European Journal of Pharmacology. 604(1-3). 45–50. 11 indexed citations

10.

Harkavyi, Alexander, Amjad Abuirmeileh, Rebecca Lever, et al.. (2008). Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease. Journal of Neuroinflammation. 5(1). 19–19. 241 indexed citations

11.

Abuirmeileh, Amjad, Rebecca Lever, Ann E. Kingsbury, et al.. (2007). The corticotrophin‐releasing factor‐like peptide urocortin reverses key deficits in two rodent models of Parkinson's disease. European Journal of Neuroscience. 26(2). 417–423. 33 indexed citations

12.

Abuirmeileh, Amjad, Alexander Harkavyi, Rebecca Lever, Christopher S. Biggs, & Peter S. Whitton. (2007). Urocortin, a CRF-like peptide, restores key indicators of damage in the substantia nigra in a neuroinflammatory model of Parkinson's disease. Journal of Neuroinflammation. 4(1). 19–19. 18 indexed citations

13.

Moffatt, James D., et al.. (2006). Activation of corticotropin‐releasing factor receptor‐2 causes bronchorelaxation and inhibits pulmonary inflammation in mice. The FASEB Journal. 20(11). 1877–1879. 21 indexed citations

14.

Moffatt, James D., Rebecca Lever, & Clive Page. (2004). Effects of inhaled thrombin receptor agonists in mice. British Journal of Pharmacology. 143(2). 269–275. 29 indexed citations

15.

Johnson, Zoë, Marie Kosco‐Vilbois, Suzanne Herren, et al.. (2004). Interference with Heparin Binding and Oligomerization Creates a Novel Anti-Inflammatory Strategy Targeting the Chemokine System. The Journal of Immunology. 173(9). 5776–5785. 126 indexed citations

16.

Pitchford, Simon C., Hiroshi Yano, Rebecca Lever, et al.. (2003). Platelets are essential for leukocyte recruitment in allergic inflammation. Journal of Allergy and Clinical Immunology. 112(1). 109–118. 165 indexed citations

17.

Lever, Rebecca. (2001). iNOS in arthritis – inducible or innocent?. Trends in Pharmacological Sciences. 22(5). 220–221. 2 indexed citations

18.

Lever, Rebecca, J.R.S. Hoult, & Clive Page. (2000). The effects of heparin and related molecules upon the adhesion of human polymorphonuclear leucocytes to vascular endothelium in vitro. British Journal of Pharmacology. 129(3). 533–540. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Schmid Breakdown of academic impact, for papers by Mónika Göőz Breakdown of academic impact, for papers by Yutaka Imamura Breakdown of academic impact, for papers by Keisuke Okabe Breakdown of academic impact, for papers by Julia Winkler Breakdown of academic impact, for papers by Heming Wu Breakdown of academic impact, for papers by Kamlesh Asotra Breakdown of academic impact, for papers by R.A.D. Bunning